Direct-to-Patient Survey Results Summary
Health Care, Innovation, Supply Chain
During the 2022 GCSG US conference in San Antonio, 65 attendees participated in our Direct-to-Patient (DtP) survey. While 2/3rd’s of the respondents represented pharmaceutical companies / sponsors, there is also a strong mix of input from service providers. Over 50% of participants also had experience with DtP. Though a need for technology improvements was noted, our industry’s adoption of patient centric services like DTP continues to boost the growth of decentralized trials.
Related Education Resources.
All ResourcesPreparing for the Post-Brexit Clinical Supply Chain
Topics: Pharma Industry, Regulatory
Position Paper
Free
Dave Mitchell Webinar Series
Topics: Communication, Leadership, Personal Development, Team Building
Webinar
Members
Challenges of the Cell, Gene, CAR-T and Personalized Medicine Supply Chains
Topics: Cold Chain, Conference, Supply Chain
Video
Members